FOUR-YEAR EFFECTIVENESS OF COVID-19 VACCINES AGAINST SEVERE DISEASE AND ASYMPTOMATIC INFECTION: THE COVIDVAC@SPAIN STUDY

Study identification

• EU PAS number:
  EUPAS43186
• Study ID:
  43187
• Official title and acronym:
  FOUR-YEAR EFFECTIVENESS OF COVID-19 VACCINES AGAINST SEVERE DISEASE AND ASYMPTOMATIC INFECTION: THE COVIDVAC@SPAIN STUDY
• DARWIN EU® study:
  No
• Study countries:
  Spain
• Study description:
  Retrospective observational epidemiological study
• Study status:
  Planned

Research institutions and networks

Institutions

Hospital La Paz

School of Medicine

Clinical Pharmacology Department, Hospital La Paz, School of Medicine

Spain

Networks

SCReN

Study timelines

Date when funding contract was signed

Planned:30/09/2021

Study start date

Planned:04/10/2021

Date of final study report

Planned:30/09/2025

Sources of funding

Other

More details on funding

Instituto de Salud Carlos III

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable